Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$209.01 - $232.56 $887,874 - $987,914
4,248 Added 10.16%
46,060 $10.1 Billion
Q4 2023

Feb 12, 2024

SELL
$197.69 - $227.29 $80,459 - $92,507
-407 Reduced 0.96%
41,812 $9.5 Billion
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $27,744 - $30,594
-138 Reduced 0.33%
42,219 $8.49 Billion
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $8.98 Million - $10.2 Million
42,357 New
42,357 $10.2 Billion

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Uni Super Management Pty LTD Portfolio

Follow Uni Super Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uni Super Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uni Super Management Pty LTD with notifications on news.